Journal of Cell Science & Therapy

Journal of Cell Science & Therapy
Open Access

ISSN: 2157-7013

+44 1300 500008

Journal of Cell Science & Therapy : Citations & Metrics Report

Articles published in Journal of Cell Science & Therapy have been cited by esteemed scholars and scientists all around the world. Journal of Cell Science & Therapy has got h-index 17, which means every article in Journal of Cell Science & Therapy has got 17 average citations.

Following are the list of articles that have cited the articles published in Journal of Cell Science & Therapy.

  2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010

Total published articles

58 54 60 54 22 4 8 20 27 54 45 16 43 23 2

Research, Review articles and Editorials

1 3 4 19 10 3 5 18 18 38 34 16 39 21 2

Research communications, Review communications, Editorial communications, Case reports and Commentary

47 51 56 25 12 1 3 2 9 16 11 0 4 2 0

Conference proceedings

0 13 42 0 0 54 115 62 70 99 230 132 86 172 0

Citations received as per Google Scholar, other indexing platforms and portals

96 154 171 199 172 155 159 147 128 90 35 28 14 23 0
Journal total citations count 1608
Journal impact factor 2.87
Journal 5 years impact factor 5.10
Journal cite score 5.53
Journal h-index 17
Journal h-index since 2019 13
Important citations (712)

The impact of the extent of thyroid resection complemented by radioiodine management on disease free status and discharge rates among differentiated thyroid cancer patients: a retrospective analysis.

Pyramidal lobe decreases endogenous tsh stimulation without impact on radio-iodine therapy outcome in patients with differentiated thyroid cancer.

Pituitary, gonadal, thyroid hormones and endocrine disruptors in pre and postmenopausal nigerian women with er-, pr- and her-2-positive and negative breast cancers.

Interleukin-27 protects cardiomyocyte-like h9c2 cells against metabolic syndrome: role of stat3 signaling

Thymoquinone dose-dependently attenuates myocardial injury induced by isoproterenol in rats via integrated modulations of oxidative stress, inflammation, apoptosis, autophagy, and fibrosis.

Targeting the ecirp/trem-1 interaction with a small molecule inhibitor improves cardiac dysfunction in neonatal sepsis.

Fgf13 is a novel regulator of nf-?b and potentiates pathological cardiac hypertrophy.

impact of sglt2 inhibitors on heart failure: from pathophysiology to clinical effects.

Comparative effects of parent and heated cinnamaldehyde on the function of human ipsc-derived cardiac myocytes

Proinflammatory cytokines and ageing of the cardiovascular-renal system.

Management of inflammation in cardiovascular diseases.

Post-ttm rebound pyrexia after ischemia-reperfusion injury results in sterile inflammation and apoptosis in cardiomyocytes.

Phosphorylation of hsp20 promotes fibrotic remodeling and heart failure

pathophysiology of cancer therapy-provoked atrial fibrillation

Fibrosis in chronic kidney disease: pathogenesis and consequences

Sodium-glucose cotransporter 2 inhibitors represent a paradigm shift in the prevention of heart failure in type 2 diabetes patients.

Absent in melanoma 2 (aim2) limits pro-inflammatory cytokine transcription in cardiomyocytes by inhibiting stat1 phosphorylation.

Temporal cardiac remodeling post-myocardial infarction: dynamics and prognostic implications in personalized medicine

Inhibition of sars-cov-2 infection in human cardiomyocytes by targeting the sigma-1 receptor disrupts cytoskeleton architecture and contractility

The role of bone morphogenetic protein 7 (bmp-7) in inflammation in heart diseases

Top